by Indigo | Dec 21, 2021 | 2021, News
BELGIUM – Ghent, December 21, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today provides an update on recent and ongoing business activities. Clinical study progress The GLOW study, which...
by Indigo | Dec 21, 2021 | 2021, News
We are pleased to announce the appointment of daniel verstappen as VP Quality assurance and regulatory affairs – Brings almost three decades of leadership experience in the MedTech space – Helped drive the transformation of Philip Morris International into...
by Indigo | May 12, 2021 | 2021, News
We are pleased to announce the appointment of Paul Moraviec as Chairman of our Board of Directors Paul Moraviec – Brings decades of leadership experience in the Global MedTech sector – As CEO of ConvaTec Group Plc, led the $5 billion IPO on the London...
by Indigo | Mar 31, 2021 | 2021, News
Our CEO and co-founder Danaë Delbeke was one of the 35 CEOs from start-ups and unicorn companies (companies worth more than $1bn), who met on 30th March 2021 in a digital roundtable event organised by the European Commission. The aim of the event which was hosted by...
by Indigo | Mar 18, 2021 | 2021, News
Ground-breaking subcutaneous sensor aims to continuously monitor multiple metabolites including ketones in people living with diabetes BELGIUM – Ghent, March 18, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions...
